Mitochondria in colorectal cancer stem cells - a target in drug resistance

Abstract

Colorectal cancer (CRC) is the third most diagnosed cancer and the second most deadly type of cancer worldwide. In late diagnosis, CRC can resist therapy regimens in which cancer stem cells (CSCs) are intimately related. CSCs are a subpopulation of tumor cells responsible for tumor initiation and maintenance, metastasis, and resistance to conventional treatments. In this scenario, colorectal cancer stem cells (CCSCs) are considered an important key for therapeutic failure and resistance. In its turn, mitochondria is an organelle involved in many mechanisms in cancer, including chemoresistance of cytotoxic drugs due to alterations in mitochondrial metabolism, apoptosis, dynamics, and mitophagy. Therefore, it is crucial to understand the mitochondrial role in CCSCs regarding CRC drug resistance. It has been shown that enhanced anti-apoptotic protein expression, mitophagy rate, and addiction to oxidative phosphorylation are the major strategies developed by CCSCs to avoid drug insults. Thus, new mitochondria-targeted drug approaches must be explored to mitigate CRC chemoresistance via the ablation of CCSCs.

Keywords

Cancer stem cells / mitochondria / colorectal cancer / drug resistance / mitophagy

References

[1] Azwar S,Abdullah M,Mohtarrudin N.Recent updates on mechanisms of resistance to 5-fluorouracil and reversal strategies in colon cancer treatment.Biology2021;10:854 PMCID:PMC8466833

[2] Das PK,Lam AK.The roles of cancer stem cells and therapy resistance in colorectal Carcinoma.Cells2020;9:1392 PMCID:PMC7348976

[3] Latham A,Kemel Y.Microsatellite instability is associated with the presence of lynch syndrome pan-cancer.J Clin Oncol2019;37:286-95

[4] Luo XJ,Liu J.Novel genetic and epigenetic biomarkers of prognostic and predictive significance in stage II/III colorectal cancer.Mol Ther2021;29:587-96 PMCID:PMC7854353

[5] Papaccio F,Gimeno-Valiente F.“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”.J Exp Clin Cancer Res2023;42:8 PMCID:PMC9817273

[6] Ooft SN,Dijkstra KK.Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients.Sci Transl Med2019;11:eaay2574

[7] Najafi M,Majidpoor J.Cancer stem cell (CSC) resistance drivers.Life Sci2019;234:116781

[8] Huang B,Li Y.Cancer stem cell for tumor therapy.Cancers2021;13:4814 PMCID:PMC8508418

[9] Batlle E.Cancer stem cells revisited.Nat Med2017;23:1124-34

[10] Hervieu C,Battu S.The role of cancer stem cells in colorectal cancer: from the basics to novel clinical trials.Cancers2021;13:1092 PMCID:PMC7961892

[11] Lee SH,Anant S.Regulatory role of quiescence in the biological function of cancer stem cells.Stem Cell Rev Rep2020;16:1185-207

[12] Francescangeli F,De Angelis ML.A pre-existing population of ZEB2⁺ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer.J Exp Clin Cancer Res2020;39:2 PMCID:PMC6947904

[13] Cannino G,Masgras I,Rasola A.Metabolic plasticity of tumor cell mitochondria.Front Oncol2018;8:333 PMCID:PMC6117394

[14] Jagust P,Parejo-Alonso B.Metabolism-based therapeutic strategies targeting cancer stem cells.Front Pharmacol2019;10:203 PMCID:PMC6438930

[15] Shin MK.Mitochondria-centric bioenergetic characteristics in cancer stem-like cells.Arch Pharm Res2019;42:113-27 PMCID:PMC6399179

[16] Nunnari J.Mitochondria: in sickness and in health.Cell2012;148:1145-59 PMCID:PMC5381524

[17] Vyas S,Haigis MC.Mitochondria and cancer.Cell2016;166:555-66 PMCID:PMC5036969

[18] Bokil A.Mitochondrial determinants of chemoresistance.Cancer Drug Resist2019;2:634-46 PMCID:PMC8992520

[19] Jin P,Zhou L.Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management.J Hematol Oncol2022;15:97 PMCID:PMC9290242

[20] Holohan C,Longley DB.Cancer drug resistance: an evolving paradigm.Nat Rev Cancer2013;13:714-26

[21] Robey RW,Hall MD,Bates SE.Revisiting the role of ABC transporters in multidrug-resistant cancer.Nat Rev Cancer2018;18:452-64 PMCID:PMC6622180

[22] Giddings EL,Wu MH.Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance.Nat Commun2021;12:2804 PMCID:PMC8121950

[23] Maycotte P,Goyri-Aguirre M,Reyes-Leyva J.Mitochondrial dynamics and cancer.Tumour Biol2017;39:1010428317698391

[24] Kong B,Fung E,Tsang BK.p53 is required for cisplatin-induced processing of the mitochondrial fusion protein L-Opa1 that is mediated by the mitochondrial metallopeptidase Oma1 in gynecologic cancers.J Biol Chem2014;289:27134-45 PMCID:PMC4175349

[25] Tomková V,Torrealba N.Mitochondrial fragmentation, elevated mitochondrial superoxide and respiratory supercomplexes disassembly is connected with the tamoxifen-resistant phenotype of breast cancer cells.Free Radic Biol Med2019;143:510-21

[26] Cai J,Huang Y.ERK/Drp1-dependent mitochondrial fission is involved in the MSC-induced drug resistance of T-cell acute lymphoblastic leukemia cells.Cell Death Dis2016;7:e2459 PMCID:PMC5260898

[27] Civenni G,Timpanaro A.Epigenetic control of mitochondrial fission enables self-renewal of stem-like tumor cells in human prostate cancer.Cell Metab2019;30:303-318.e6

[28] Romani P,Arboit M.Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance.Nat Cell Biol2022;24:168-80

[29] Li J,Kong LR.Targeting metabolism in cancer cells and the tumour microenvironment for cancer therapy.Molecules2020;25:4831 PMCID:PMC7588013

[30] Sica V,Stoll G.Oxidative phosphorylation as a potential therapeutic target for cancer therapy.Int J Cancer2020;146:10-7

[31] Sriramkumar S,Huntington TD.Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer.J Transl Med2022;20:246

[32] Yi M,Chen S.Emerging role of lipid metabolism alterations in cancer stem cells.J Exp Clin Cancer Res2018;37:118 PMCID:PMC6003041

[33] Wang T,Lee H.JAK/STAT3-regulated fatty acid β-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance.Cell Metab2018;27:136-150.e5 PMCID:PMC5777338

[34] Lee ACK,Kwan YW.Mitochondrial fuel dependence on glutamine drives chemo-resistance in the cancer stem cells of hepatocellular carcinoma.Int J Mol Sci2021;22:3315 PMCID:PMC8036982

[35] Nishimura T,Chen X.Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2.Oncogene2019;38:2464-81 PMCID:PMC6484769

[36] Franczak M,Jansen G,Giovannetti E.The influence of mitochondrial energy and 1C metabolism on the efficacy of anticancer drugs: exploring potential mechanisms of resistance.Curr Med Chem2023;30:1209-31

[37] Lucas S,Aras S.Serine catabolism is essential to maintain mitochondrial respiration in mammalian cells.Life Sci Alliance2018;1:e201800036 PMCID:PMC6238390

[38] Hanahan D.Hallmarks of cancer: the next generation.Cell2011;144:646-74

[39] Abate M,Falco M.Mitochondria as playmakers of apoptosis, autophagy and senescence.Semin Cell Dev Biol2020;98:139-53

[40] Indran IR,Pervaiz S.Recent advances in apoptosis, mitochondria and drug resistance in cancer cells.Biochim Biophys Acta2011;1807:735-45

[41] Singh R,Sarosiek K.Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins.Nat Rev Mol Cell Biol2019;20:175-93 PMCID:PMC7325303

[42] Xu L,Qi L.Bcl-2 overexpression reduces cisplatin cytotoxicity by decreasing ER-mitochondrial Ca2⁺ signaling in SKOV3 cells.Oncol Rep2018;39:985-92 PMCID:PMC5802038

[43] Joza N,Daugas E.Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death.Nature2001;410:549-54

[44] Alvero AB,Chen R.NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway.Cancer2009;115:3204-16 PMCID:PMC2757274

[45] Tait SW.Mitochondria and cell death: outer membrane permeabilization and beyond.Nat Rev Mol Cell Biol2010;11:621-32

[46] Ioannidou E.Angiogenesis and anti-angiogenic treatment in prostate cancer: mechanisms of action and molecular targets.Int J Mol Sci2021;22:9926 PMCID:PMC8472415

[47] Hekmatshoar Y,Galloni M.The role of metabolism and tunneling nanotube-mediated intercellular mitochondria exchange in cancer drug resistance.Biochem J2018;475:2305-28

[48] Caicedo A,Brondello JM.MitoCeption as a new tool to assess the effects of mesenchymal stem/stromal cell mitochondria on cancer cell metabolism and function.Sci Rep2015;5:9073 PMCID:PMC4358056

[49] Moschoi R,Nebout M.Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy.Blood2016;128:253-64

[50] Nzigou Mombo B,Bokus A.Mitoception: transferring isolated human MSC mitochondria to glioblastoma stem cells.J Vis Exp2017;

[51] Fialova JL,Jakubek M.Novel mitochondria-targeted drugs for cancer therapy.Mini Rev Med Chem2021;21:816-32

[52] Dilip A,Joseph J.Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma.Anticancer Drug2013;24:881-8 PMCID:PMC4028966

[53] Cheng G,Dranka BP.Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.Cancer Res2012;72:2634-44 PMCID:PMC3700358

[54] Boyle KA,Hill RB,Kalyanaraman B.Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation.J Biol Chem2018;293:14891-904 PMCID:PMC6153299

[55] Wang H.Mito-methyl coumarin, a novel mitochondria-targeted drug with great antitumor potential was synthesized.Biochem Biophys Res Commun2017;489:1-7

[56] Chan MS,Leung HM.Cancer-cell-specific mitochondria-targeted drug delivery by dual-ligand-functionalized nanodiamonds circumvent drug resistance.ACS Appl Mater Interf2017;9:11780-9

[57] Li WQ,Hao S.Mitochondria-targeting polydopamine nanoparticles to deliver doxorubicin for overcoming drug resistance.ACS Appl Mater Interf2017;9:16793-802

[58] Song IS,Jeong SH.Mitochondria as therapeutic targets for cancer stem cells.World J Stem Cells2015;7:418-27 PMCID:PMC4369497

[59] Hirsch HA,Struhl K.Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth.Proc Natl Acad Sci U S A2013;110:972-7 PMCID:PMC3549132

[60] Alvero AB,Holmberg JC,Brown D.Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells.Mol Cancer Ther2011;10:1385-93 PMCID:PMC3703662

[61] Bielcikova Z,Krizova L.Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial.EClinicalMedicine2023;57:101873 PMCID:PMC10102891

[62] Yap TA,Piha-paul SA.Phase I trial of IACS-010759 (IACS), a potent, selective inhibitor of complex I of the mitochondrial electron transport chain, in patients (pts) with advanced solid tumors.JCO2019;37:3014-3014

[63] Huang H,Li Y.Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance.Nat Commun2021;12:3720 PMCID:PMC8211793

[64] Ren Y,Wang X,Ma Y.Alterations in mitochondrial function and energy metabolism-related properties in thyroid cancer stem cells.Acta Biochim Pol2021;69:11-7

[65] Kuntz EM,Michie AM.Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells.Nat Med2017;23:1234-40 PMCID:PMC5657469

[66] Huang R,Zhong Y. Mitochondrial DNA deficiency in ovarian cancer cells and cancer stem cell-like properties. Available from: https://ar.iiarjournals.org/content/anticanres/35/7/3743.full.pdf [Last accessed on 5 May 2023]

[67] Lai HT,Tseng WK,Su Y.GATA6 enhances the stemness of human colon cancer cells by creating a metabolic symbiosis through upregulating LRH-1 expression.Mol Oncol2020;14:1327-47 PMCID:PMC7266275

[68] Aminuddin A,Leong CO.Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma.Sci Rep2020;10:7885 PMCID:PMC7217862

[69] Safa AR.Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces.Cancer Drug Resist2022;5:850-72 PMCID:PMC9771762

[70] Piggott L,Martí Pérez S,Eberl M.Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.Breast Cancer Res2011;13:R88 PMCID:PMC3262200

[71] Guo W,Fu Y.Discovering and characterizing of survivin dominant negative mutants with stronger pro-apoptotic activity on cancer cells and CSCs.Front Oncol2021;11:635233 PMCID:PMC8045750

[72] Sessions DT.Mitochondrial dynamics in cancer stem cells.Cell Mol Life Sci2021;78:3803-16

[73] Xie Q,Horbinski CM.Mitochondrial control by DRP1 in brain tumor initiating cells.Nat Neurosci2015;18:501-10 PMCID:PMC4376639

[74] Lee KM,Balko JM.MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation.Cell Metab2017;26:633-647.e7

[75] Purushothaman B,Ju H,Samson AAS.Novel ruthenium(II) triazine complex [Ru(bdpta)(tpy)]²⁺ co-targeting drug resistant GRP78 and subcellular organelles in cancer stem cells.Eur J Med Chem2018;156:747-59

[76] Colak S,Fessler E.Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells.Cell Death Differ2014;21:1170-7 PMCID:PMC4207483

[77] Ramesh P,Jackstadt R.BCL-XL is crucial for progression through the adenoma-to-carcinoma sequence of colorectal cancer.Cell Death Differ2021;28:3282-96 PMCID:PMC8630104

[78] Takeda M,Takahashi H.Disruption of endolysosomal RAB5/7 efficiently eliminates colorectal cancer stem cells.Cancer Res2019;79:1426-37

[79] Yan C,Guo CY.Doxorubicin-induced mitophagy contributes to drug resistance in cancer stem cells from HCT8 human colorectal cancer cells.Cancer Lett2017;388:34-42

[80] Denise C,Calvani M.5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.Oncotarget2015;6:41706-21 PMCID:PMC4747183

[81] Song IS,Jeong SH.FOXM1-induced PRX3 regulates stemness and survival of colon cancer cells via maintenance of mitochondrial function.Gastroenterology2015;149:1006-16.e9